Ledger.Open graph →
SEC Form D · filed October 11, 2012

GENOCEA BIOSCIENCES, INC

Offering
$30.5M
Sold
$15.3M
Exemption
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

People & firms on this filing (24)

Robert Paull · CAMBRIDGE, MADirectorKevin Bitterman · CAMBRIDGE, MADirectorTal S. Kerret · New York, NYExec · DirectorPaul Giannasca · CAMBRIDGE, MAExecLisa L. Silverstein · New York, NYExecSimeon George · CAMBRIDGE, MADirectorRavi Venkataramani · CAMBRIDGE, MAExecAsish Xavier · CAMBRIDGE, MADirectorRobert E. Farrell Jr · CAMBRIDGE, MAExecSeth Hetherington · CAMBRIDGE, MAExecMelvin L. Kupperman · New York, NYDirectorLeon Chen · Austin, TXDirectorTimothy N. Yuckman · Birmingham, ALExecTom Bacon · HOUSTON, TXDirectorJordan Jones · Birmingham, ALExec · DirectorLisa D. Earnhardt · Menlo Park, CADirectorRichard E. Kaufman · Menlo Park, CADirectorMonika A. De Martini · Menlo Park, CADirectorRick Anderson · Austin, TXDirectorFrederic H. Moll · Menlo Park, CAExecCasper De Clercq · Palo Alto, CAExecVictor Kats · St. Louis, MOExecRachel J. Cherney · Santa Ana, CAExecLeon Chen · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗